Is Alzheimer's disease, relentless and slow, a better target for clinical trials?

Published Date: 16 Feb 2023

According to a report by the Alzheimer's Association task force, it's time to reframe what "clinically meaningful" means and change expectations about clinical trials.

Read Full News

Todays Updates


WHO Declares Hantavirus Outbreak Linked to Cruise Ship Over


The World Health Organization ⁠on Thursday declared the hantavirus ⁠outbreak linked to a ⁠cruise ship ‌over after the last identified contact of an exposed person completed...

Australia's New South Wales Confirms H5N1 Bird Flu Case, Third State


New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said ⁠a migratory seabird found near a coastal town returned a positive...

Effort to End Respiratory Viruses to Start With Cold & Flu


The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

Professional Corner: Resident Well-Being, Maternity, & More


New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.

Low-Dose Atropine for Childhood Myopia: Worth Using?


A UK trial finds that low-dose atropine modestly slows childhood myopia progression and axial eye growth over 2 years without increasing adverse events.

Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL


A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.

Functional Cure for Hepatitis B Is Now ‘Achievable’


Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional cure vs none given placebo.

Todays Updates


WHO Declares Hantavirus Outbreak Linked to Cruise Ship Over


The World Health Organization ⁠on Thursday declared the hantavirus ⁠outbreak linked to a ⁠cruise ship ‌over after the last identified contact of an exposed person completed...

Australia's New South Wales Confirms H5N1 Bird Flu Case, Third State


New South Wales became Australia's third state to confirm a case of H5N1 bird flu after authorities said ⁠a migratory seabird found near a coastal town returned a positive...

Effort to End Respiratory Viruses to Start With Cold & Flu


The $500 million seed fund will support universal antiviral platforms and air cleaning technologies.

Professional Corner: Resident Well-Being, Maternity, & More


New study finds nearly 10% of internal medicine residents report a disability; the American Medical Association updates maternity care billing codes; and Texas joins autism trial network.

Low-Dose Atropine for Childhood Myopia: Worth Using?


A UK trial finds that low-dose atropine modestly slows childhood myopia progression and axial eye growth over 2 years without increasing adverse events.

Venetoclax-Obinutuzumab Boosts MRD Clearance in CLL


A phase 3 trial compares first-line fixed-duration venetoclax-obinutuzumab to fludarabine, cyclophosphamide, and rituximab/bendamustine-rituximab in patients with CLL.

Functional Cure for Hepatitis B Is Now ‘Achievable’


Bepirovirsen reduced posttreatment markers of hepatitis B infection at 72 weeks, with 20% of recipients achieving functional cure vs none given placebo.

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Encounters matter in cancer care: Health care professionals can play a key role in restoring patients' sense of control

2.

Chronic stress and obesity work together to accelerate pancreatic cancer development and growth, study finds

3.

Belzutifan Plus Pembro Approved for Adjuvant RCC

4.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

5.

Immune cell homing hydrogel-based platform captures dendritic cells to process mRNA from cancer vaccines


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot